查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球皮膚科 CRO 市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測
市場調查報告書
商品編碼
1421119

全球皮膚科 CRO 市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Dermatology CRO Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

預計到 2032 年，全球皮膚科 CRO 市場的市場規模將從 2023 年的 56.7 億美元達到近 106.5 億美元，2024-2032 年研究期間複合CAGR為 7.25%。

皮膚科 CRO 代表皮膚科合約研究組織。 CRO 是一家為製藥、生技和醫療器材產業提供研究服務的公司。在皮膚病學方面，這些組織專門從事與皮膚疾病和病症相關的臨床試驗和研究。它們在幫助製藥公司和研究人員收集資料、進行試驗以及指導與開發新的皮膚病治療或療法相關的監管流程方面發揮著至關重要的作用。

市場動態

皮膚科合約研究組織 (CRO) 市場受到幾個關鍵因素的推動。皮膚病患病率的上升刺激了對創新治療的需求，推動了皮膚病學的研究和開發活動。科技的進步和向個人化醫療的轉變進一步加劇了對該領域專業研究服務的需求。製藥公司擴大將臨床試驗活動外包給 CRO，受益於他們的專業知識和基礎設施，同時專注於核心能力。皮膚病學研究的複雜性和不斷變化的監管指南導致越來越依賴 CRO 服務來應對這些挑戰。隨著製藥業繼續優先考慮外包以及皮膚病學研究變得更加複雜，皮膚病學 CRO 市場持續成長，在推動各種皮膚病新療法和治療方法的開發方面發揮著至關重要的作用。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球皮膚病學市場的每個細分市場進行了包容性評估。皮膚科微生物產業的成長和趨勢為本研究提供了整體方法。

市場區隔

皮膚科 cro 市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按類型

  • 藥物發現（標靶驗證、先導化合物辨識、先導化合物最佳化）
  • 臨床前
  • 臨床（I期、II期、III期、IV期）

按服務

  • 專案管理/臨床供應管理
  • 資料管理
  • 監管/醫療事務
  • 醫學寫作
  • 臨床監測
  • 品質管理/保證
  • 生物統計學
  • 研究者付款
  • 實驗室
  • 患者和現場招募
  • 科技
  • 其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲皮膚科 CRO 市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。皮膚科 CRO 市場的主要參與者包括 IQVIA Inc.、Labcorp Drug Development、Pharmaceutical Product Development, LLC (PPD) (Thermo Fisher Scientific Inc.)、Parexel International Corp.、Charles River Laboratories、Icon, Plc、Medidata、Syneos Health 、康龍化成、雷根生命科學有限公司、藥明康德、MEDPACE、CTI 臨床試驗與諮詢、Bioskin、Proinnovera GmbH、Biorasi, LLC、Javara、TFS。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：皮膚科 CRO - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按類型分類的市場吸引力分析
    • 按服務分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球皮膚科 CRO 市場分析：按類型

  • 按類型概述
  • 歷史和預測數據
  • 按類型分析
  • 藥物發現（標靶驗證、先導化合物辨識、先導化合物最佳化）
  • 臨床前
  • 臨床（I期、II期、III期、IV期）

第 6 章：全球皮膚科 CRO 市場分析：依服務分類

  • 按服務概覽
  • 歷史和預測數據
  • 按服務分析
  • 專案管理/臨床供應管理
  • 資料管理
  • 監管/醫療事務
  • 醫學寫作
  • 臨床監測
  • 品質管理/保證
  • 生物統計學
  • 研究者付款
  • 實驗室
  • 患者和現場招募
  • 科技
  • 其他

第 7 章：全球皮膚科 CRO 市場分析：依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 8 章：皮膚科 CRO 公司的競爭格局

  • 皮膚科Cro市場競賽
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 9 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • IQVIA Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Labcorp Drug Development
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Pharmaceutical Product Development LLC (PPD) (Thermo Fisher Scientific Inc.)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Parexel International Corp.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Charles River Laboratories
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Icon PLC
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Medidata
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Syneos Health
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Pharmaron
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • ragen Life Sciences Ltd.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Wuxi AppTec
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • MEDPACE
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • CTI Clinical Trial & Consulting
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Bioskin
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Proinnovera GmbH
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Biorasi LLC
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Javara
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • TFS
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

Product Code: VMR112113390

The global demand for Dermatology CRO Market is presumed to reach the market size of nearly USD 10.65 BN by 2032 from USD 5.67 BN in 2023 with a CAGR of 7.25% under the study period 2024 - 2032.

Dermatology CRO stands for Dermatology Contract Research Organization. CROs are companies that provide research services to the pharmaceutical, biotechnology, and medical device industries. In the context of dermatology, these organizations specialize in conducting clinical trials and research related to skin disorders and conditions. They play a crucial role in helping pharmaceutical companies and researchers gather data, conduct trials, and navigate the regulatory processes associated with developing new dermatological treatments or therapies.

MARKET DYNAMICS

The Dermatology Contract Research Organization (CRO) market is propelled by several key factors. The rising prevalence of skin disorders has spurred the demand for innovative treatments, driving research and development activities in dermatology. Advancements in technology and the shift towards personalized medicine have further intensified the need for specialized research services in this field. Pharmaceutical companies increasingly outsource clinical trial activities to CROs, benefiting from their expertise and infrastructure while focusing on core competencies. The complexity of dermatology research and evolving regulatory guidelines contribute to the growing reliance on CRO services to navigate these challenges. As the pharmaceutical industry continues to prioritize outsourcing and as dermatological research becomes more intricate, the dermatology CRO market experiences sustained growth, playing a crucial role in advancing the development of new therapies and treatments for various skin conditions.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of dermatology cro. The growth and trends of dermatology cro industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the dermatology cro market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Drug Discovery (Target Validation, Lead Identification, Lead Optimization)
  • Preclinical
  • Clinical (Phase I, Phase Ii, Phase Iii, Phase Iv)

By Service

  • Project Management/Clinical Supply Management
  • Data Management
  • Regulatory/Medical Affairs
  • Medical Writing
  • Clinical Monitoring
  • Quality Management/Assurance
  • Bio-Statistics
  • Investigator Payments
  • Laboratory
  • Patient And Site Recruitment
  • Technology
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Dermatology CRO market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Dermatology CRO market include IQVIA Inc., Labcorp Drug Development, Pharmaceutical Product Development, LLC (PPD) (Thermo Fisher Scientific Inc.), Parexel International Corp., Charles River Laboratories, Icon, Plc, Medidata, Syneos Health, Pharmaron, ragen Life Sciences Ltd., Wuxi AppTec, MEDPACE, CTI Clinical Trial & Consulting, Bioskin, Proinnovera GmbH, Biorasi, LLC, Javara, TFS. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . DERMATOLOGY CRO - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Service
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL DERMATOLOGY CRO MARKET ANALYSIS BY TYPE

  • 5.1 Overview by Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Type
  • 5.4 Drug Discovery (Target Validation, Lead Identification, Lead optimization) Historic and Forecast Sales by Regions
  • 5.5 Preclinical Historic and Forecast Sales by Regions
  • 5.6 Clinical (Phase I, Phase II, Phase III, Phase IV) Historic and Forecast Sales by Regions

6 . GLOBAL DERMATOLOGY CRO MARKET ANALYSIS BY SERVICE

  • 6.1 Overview by Service
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Service
  • 6.4 Project Management/Clinical Supply Management Historic and Forecast Sales by Regions
  • 6.5 Data Management Historic and Forecast Sales by Regions
  • 6.6 Regulatory/Medical Affairs Historic and Forecast Sales by Regions
  • 6.7 Medical Writing Historic and Forecast Sales by Regions
  • 6.8 Clinical Monitoring Historic and Forecast Sales by Regions
  • 6.9 Quality Management/Assurance Historic and Forecast Sales by Regions
  • 6.10. Bio-statistics Historic and Forecast Sales by Regions
  • 6.11 Investigator Payments Historic and Forecast Sales by Regions
  • 6.12 Laboratory Historic and Forecast Sales by Regions
  • 6.13 Patient and Site Recruitment Historic and Forecast Sales by Regions
  • 6.14 Technology Historic and Forecast Sales by Regions
  • 6.15 Others Historic and Forecast Sales by Regions

7 . GLOBAL DERMATOLOGY CRO MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2. North America By Segment Sales Analysis
    • 7.3.3. North America By Country Sales Analysis
    • 7.3.4. United State Sales Analysis
    • 7.3.5. Canada Sales Analysis
    • 7.3.6. Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2. Europe by Segment Sales Analysis
    • 7.4.3. Europe by Country Sales Analysis
    • 7.4.4. United Kingdom Sales Analysis
    • 7.4.5. France Sales Analysis
    • 7.4.6. Germany Sales Analysis
    • 7.4.7. Italy Sales Analysis
    • 7.4.8. Russia Sales Analysis
    • 7.4.9. Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2. Asia Pacific by Segment Sales Analysis
    • 7.5.3. Asia Pacific by Country Sales Analysis
    • 7.5.4. China Sales Analysis
    • 7.5.5. India Sales Analysis
    • 7.5.6. Japan Sales Analysis
    • 7.5.7. South Korea Sales Analysis
    • 7.5.8. Australia Sales Analysis
    • 7.5.9. South East Asia Sales Analysis
    • 7.5.10. Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2. Latin America by Segment Sales Analysis
    • 7.6.3. Latin America by Country Sales Analysis
    • 7.6.4. Brazil Sales Analysis
    • 7.6.5. Argentina Sales Analysis
    • 7.6.6. Peru Sales Analysis
    • 7.6.7. Chile Sales Analysis
    • 7.6.8. Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2. Middle East & Africa by Segment Sales Analysis
    • 7.7.3. Middle East & Africa by Country Sales Analysis
    • 7.7.4. Saudi Arabia Sales Analysis
    • 7.7.5. UAE Sales Analysis
    • 7.7.6. Israel Sales Analysis
    • 7.7.7. South Africa Sales Analysis
    • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE DERMATOLOGY CRO COMPANIES

  • 8.1. Dermatology Cro Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF DERMATOLOGY CRO INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. IQVIA Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Company Revenue
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. Labcorp Drug Development
    • 9.4.1. Company Overview
    • 9.4.2. Company Revenue
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. Pharmaceutical Product Development LLC (PPD) (Thermo Fisher Scientific Inc.)
    • 9.5.1. Company Overview
    • 9.5.2. Company Revenue
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. Parexel International Corp.
    • 9.6.1. Company Overview
    • 9.6.2. Company Revenue
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Charles River Laboratories
    • 9.7.1. Company Overview
    • 9.7.2. Company Revenue
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. Icon PLC
    • 9.8.1. Company Overview
    • 9.8.2. Company Revenue
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. Medidata
    • 9.9.1. Company Overview
    • 9.9.2. Company Revenue
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Syneos Health
    • 9.10.1. Company Overview
    • 9.10.2. Company Revenue
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. Pharmaron
    • 9.11.1. Company Overview
    • 9.11.2. Company Revenue
    • 9.11.3. Products
    • 9.11.4. Recent Developments
  • 9.12. ragen Life Sciences Ltd.
    • 9.12.1. Company Overview
    • 9.12.2. Company Revenue
    • 9.12.3. Products
    • 9.12.4. Recent Developments
  • 9.13. Wuxi AppTec
    • 9.13.1. Company Overview
    • 9.13.2. Company Revenue
    • 9.13.3. Products
    • 9.13.4. Recent Developments
  • 9.14. MEDPACE
    • 9.14.1. Company Overview
    • 9.14.2. Company Revenue
    • 9.14.3. Products
    • 9.14.4. Recent Developments
  • 9.15. CTI Clinical Trial & Consulting
    • 9.15.1. Company Overview
    • 9.15.2. Company Revenue
    • 9.15.3. Products
    • 9.15.4. Recent Developments
  • 9.16. Bioskin
    • 9.16.1. Company Overview
    • 9.16.2. Company Revenue
    • 9.16.3. Products
    • 9.16.4. Recent Developments
  • 9.17. Proinnovera GmbH
    • 9.17.1. Company Overview
    • 9.17.2. Company Revenue
    • 9.17.3. Products
    • 9.17.4. Recent Developments
  • 9.18. Biorasi LLC
    • 9.18.1. Company Overview
    • 9.18.2. Company Revenue
    • 9.18.3. Products
    • 9.18.4. Recent Developments
  • 9.19. Javara
    • 9.19.1. Company Overview
    • 9.19.2. Company Revenue
    • 9.19.3. Products
    • 9.19.4. Recent Developments
  • 9.20. TFS
    • 9.20.1. Company Overview
    • 9.20.2. Company Revenue
    • 9.20.3. Products
    • 9.20.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Type (USD MN)
  • Drug Discovery (Target Validation, Lead Identification, Lead optimization) Market Sales by Geography (USD MN)
  • Preclinical Market Sales by Geography (USD MN)
  • Clinical (Phase I, Phase II, Phase III, Phase IV) Market Sales by Geography (USD MN)
  • Analysis Market by Service (USD MN)
  • Project Management/Clinical Supply Management Market Sales by Geography (USD MN)
  • Data Management Market Sales by Geography (USD MN)
  • Regulatory/Medical Affairs Market Sales by Geography (USD MN)
  • Medical Writing Market Sales by Geography (USD MN)
  • Clinical Monitoring Market Sales by Geography (USD MN)
  • Quality Management/Assurance Market Sales by Geography (USD MN)
  • Bio-statistics Market Sales by Geography (USD MN)
  • Investigator Payments Market Sales by Geography (USD MN)
  • Laboratory Market Sales by Geography (USD MN)
  • Patient and Site Recruitment Market Sales by Geography (USD MN)
  • Technology Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Dermatology Cro Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Dermatology Cro Report
  • Market Research Process
  • Market Research Methodology
  • Global Dermatology Cro Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Service
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Drug Discovery (Target Validation, Lead Identification, Lead optimization) Market Sales by Geography (USD MN)
  • Preclinical Market Sales by Geography (USD MN)
  • Clinical (Phase I, Phase II, Phase III, Phase IV) Market Sales by Geography (USD MN)
  • Global Market Analysis by Service (USD MN)
  • Project Management/Clinical Supply Management Market Sales by Geography (USD MN)
  • Data Management Market Sales by Geography (USD MN)
  • Regulatory/Medical Affairs Market Sales by Geography (USD MN)
  • Medical Writing Market Sales by Geography (USD MN)
  • Clinical Monitoring Market Sales by Geography (USD MN)
  • Quality Management/Assurance Market Sales by Geography (USD MN)
  • Bio-statistics Market Sales by Geography (USD MN)
  • Investigator Payments Market Sales by Geography (USD MN)
  • Laboratory Market Sales by Geography (USD MN)
  • Patient and Site Recruitment Market Sales by Geography (USD MN)
  • Technology Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.